On the other hand, COX-2 inhibition did not impact PD-L1 levels of lung cancer cells [46], or only affected tumor-associated macrophages and myeloid-derived suppressor cells [41], or decreased PD-L1 by a COX-2/PGE2 independent pathway in breast cancer cells [74]. This evidence concerns the gene CD274 and neoplasm.